生物启发的纤维素捕捉微球使得在高压血静下能够形成超生理凝块
Yuanyuan Ding1, Ting Wang2, Jing Li1
1National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, Sichuan, China.
Advanced healthcare materials
|December 19, 2025
概括
通过迅速形成稳定的血块,新的酸胺凝微球可以迅速阻止严重的出血. 这些先进的血液静止剂通过改善凝块稳定性和减少血液损失,对紧急护理充满希望.
科学领域:
- 生物材料科学 生物材料科学
- 血液静止研究 血液静止研究
- 医疗器械开发 医疗器械开发
背景情况:
- 在高压出血中有效的静血对于常规药物来说是具有挑战性的.
- 由于不能快速隔离纤维素并形成稳定的血块,目前的治疗方法受到限制.
研究的目的:
- 开发酸酸盐 (HAp) 合物凝微球 (GHMPs-10) 增强血静.
- 调查GHMPs-10加速凝血和稳定严重出血中的血块的能力.
主要方法:
- 制造HAp兴奋剂凝微球 (GHMPs-10).
- 在体外评估纤维素素招募和凝块形成.
- 在体外测量液体吸收和微球膨胀.
- 在体外破裂压力测试.
- 在多个动物模型中的体内评估血静效率.
主要成果:
- GHMPs-10促进了纤维素素的快速招募和强大的纤维素网络组装.
- 微球膨胀 (≈718%) 集中了凝固因子,并机械地封闭了该区域.
- GHMPs-10表现出高爆压阻力 (≈191.5毫米升).
- 与商业药物相比,在动物模型中显著减少了静血时间和血液损失.
结论:
- GHMPs-10有效地启动凝血并集中血液成分.
- 微球形成机械坚固的水凝凝块,用于快速静血.
- 这些纤维素素捕获微球代表了在紧急血液静止中临床转化的一个有希望的候选人.
相关概念视频
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Formation of the Platelet Plug
8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
Introduction to Hemostasis
13.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.0K
Coagulation
9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K


